Avient Announces Second Quarter 2026 Results

Avient Corporation announced its second-quarter results for 2026. Second-quarter sales grew 5.8% to $917 million, driven by 4.3% organic sales growth and 1.5% favorable foreign-exchange effects, with organic growth in both business segments. 

Second quarter GAAP earnings per share (EPS) were $0.70 compared to $0.57 in the prior year quarter.

Second quarter adjusted EPS grew 20% over the prior year to $0.96, exceeding adjusted EPS guidance of $0.89, primarily driven by better-than-expected organic volume growth. 

“Our teams delivered another quarter of strong execution, generating organic growth and adjusted EBITDA margin expansion in each of our two business segments. By remaining close to our customers, proactively managing inflation and supply chain disruptions, we delivered profitable growth across the portfolio,” said Dr. Ashish Khandpur, Chairman, President and Chief Executive Officer, Avient Corporation. 

“Organic sales growth was driven by a combination of market share gains, new product innovation, and pricing actions.  Our performance reflects the team’s execution of our strategy to intersect Avient’s capabilities with high-growth secular trends while driving productivity improvements to enable both top-line growth and margin expansion.  As a result, organic sales grew 4.3% and adjusted EBITDA margins expanded by 110 basis points to a record high 18.3%.” added Dr. Khandpur.

With these results, Avent is increasing 2026 full-year adjusted EPS guidance range to $3.10 to $3.25 from previous guidance of $2.93 to $3.17. The updated full-year adjusted EPS guidance range represents 10% to 15% growth over the prior year.